June 4, 2020
This newly minted University of Cincinnati graduate has decided to stay a Bearcat by pursuing her graduate degree. Stephanie Knechtly was set to start a job at The Walt Disney Co. when the COVID-19 pandemic brought her plans to a screeching halt.
May 28, 2020
Two University of Cincinnati students have developed an interactive dashboard which shows COVID-19 cases and deaths in Greater Cincinnati and other major U.S. cities. Known as the COVID-19 Watcher, it joins a list of options available to the public to track the novel coronavirus.
July 28, 2020
UC College-Conservatory of Music (CCM) DMA Piano student Kara Huber and Piano Professor Michelle Conda speak to Cincinnati Business Courier reporter Janelle Gelfand about the challenges of teaching music virtually during the COVID-19 pandemic.
August 6, 2020
A center to provide space for racial healing and address social injustice through research and community dialogue opens this summer at the University of Cincinnati’s College of Arts and Sciences (A&S). The Center for Truth, Racial Healing and Transformation (TRT) at UC will join a nationwide network of 22 similar centers at higher education institutions partnering with the American Association of Colleges and Universities (AAC&U) . Since 2018, the AAC&U has established centers across the country, from the University of California, Irvine to Duke University to The Citadel, The Military College of South Carolina.
July 14, 2020
Ahmad Sedaghat, MD, PhD, conducted a prospective, cross-sectional telephone questionnaire study which examined characteristics and symptoms of 114 patients who were diagnosed with COVID-19 over a six-week period at Kantonsspital Aarau in Aarau, Switzerland. Depressed mood or anxiety exhibited in COVID-19 patients may possibly be a sign the virus affects the central nervous system, according to Sedaghat, a University of Cincinnati College of Medicine researcher.
July 15, 2020
Researchers at UC are testing a commonly used drug, called sirolimus, to determine its safety and efficacy in treating hospitalized patients with COVID-19 pneumonia in the trial. The research trial, called Sirolimus Treatment in Hospitalized Patients with COVID-19 Pneumonia (SCOPE), will examine the Food and Drug Administration-approved medication that is most commonly used to prevent organ rejection in patients with kidney transplants. It is also FDA-approved for the treatment of a rare lung disease, LAM.